Best Biopharma Outsourcing Companies in Germany
The 366 best Biopharma Outsourcing companies in Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: CHEPLAPHARM.
Germany's Biopharma Outsourcing sector has 366 tracked companies and $772M in disclosed funding, and if you're trying to find the best-funded operators, this directory ranks them by exactly that. No unicorns yet, but the concentration is real: Cheplapharm alone accounts for $547M of that total, Aenova Group adds another $113M, and the remaining field splits a comparatively thin slice. The global market sits at $28.7B in 2024 and is forecast to reach $112.3B by 2032, a 5.8% CAGR driven by biologics demand and climbing drug development costs. Regulatory compliance pressure is tightening across the EU, which tends to push more work toward specialized outsourcing partners rather than in-house teams.
So what's actually moving the needle this quarter? Clinical trial outsourcing and operational resilience are the hot themes, and median app-install growth across outsourcing verticals is running at roughly 13% year-over-year, which tells you the digital infrastructure side of this market is expanding fast. I'd watch HQS Quantum Simulations ($16M) as a signals-ahead-of-the-curve bet, given where computational drug development is heading. Investors like HTGF and Auctus Capital Partners are the most active names in the German cohort, which matters when you're sizing up who's likely to back the next funding round.
- ResearchAndMarkets.com
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Germany
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CHEPLAPHARM Pharmaceutical company that specializes in the development, marketing, and distribution of branded… | $547M | 43 mo ago | 840 840 → 503 (-40%) · sector median -12% | Kurt Teubner Founder | TYPO3 CMSPHPTailwind CSS+12 | Top 5M | — | — |
| 2 | Aenova Group CDMO offering its services for pharmaceuticals, medical devices and nutraceuticals | $113M | 75 mo ago | 4,200 | — | Cart FunctionalityCraft CMSApple iCloud Mail+15 | Top 5M | 4 patents Formulating and manufacturing proton pump inhibitor pharmaceutical compositions and dosage forms. | 2 job openings |
| 3 | Jennewein Biotechnologie Provider of nutritional, pharmaceutical, cosmetic and medical applications product development & research… | $18M | 94 mo ago | 105 | — | — | — | 358 patents Engineered microbial production and enzymatic purification of human milk oligosaccharides | — |
| 4 | Leukocare Developer of proprietary stabilizing and protecting solutions for biologics formulation | $18M | 59 mo ago | 70 70 → 56 (-20%) · sector median -12% | Michael Scholl Chief Executive Officer; Co-Founder | Framer SitesReactCloudflare+13 | Top 50M | 132 patents Fibrin sealant hemostatics, high‑concentration biopharma formulations, and viral vector delivery systems. | — |
| 5 | HQS Quantum Simulations Developer of quantum simulation software for spectroscopy and related techniques | $16M | 16 mo ago | 29 29 → 42 (+45%) · sector median -12% | — | Cart FunctionalitySquarespace CommerceSquarespace+13 | Top 50M | 49 patents Quantum algorithms for noisy molecular simulation and error mitigation in quantum computing | — |
| 6 | Cellca Specialty company that develops protein-specific cell lines and upstream processes in mammalian cells | $11M | 241 mo ago | 30 | Hugo De Wit CEO | — | — | 27 patents Optimized serum‑free mammalian cell culture media and additives for bioproduction | — |
| 7 | FundaMental Pharma Provider of drug development & research services for peptides & gene therapy, and neurological diseases | $10M | 42 mo ago | — | Daniela Mauceri Co-Founder | Cart FunctionalitySquarespace CommerceSquarespace+11 | Top 50M | — | — |
| 8 | DUDE CHEM Manufacturer of green active pharmaceutical ingredients and pharmaceutical intermediate chemicals | $7M | 28 mo ago | 16 | Mathis Han Co-Founder & Chief Data Scientist (Cds) | Cart FunctionalitySquarespace CommerceSquarespace+12 | Top 50M | — | 1 award |
| 9 | Palleos Provider of contract research organization services for pharmaceutical and biotech industries | $5M | 70 mo ago | 50 | Philip Raeth Managing Director | WebflowWordPressMySQL+17 | Top 10M | — | — |
| 10 | ProtaGene Provider of drug development services for cell & gene therapeutic services | $5M | 152 mo ago | 55 | — | WordPressMySQLPHP+26 | Top 10M | — | 1 job opening |
| 11 | Genome Biologics Developer of therapies for cardiovascular and cardiometabolic diseases | $3M | 57 mo ago | 12 | Jonathan Ward Co-Founder | — | — | 23 patents Human cardiac organoid and tissue-mimetic platforms for disease modeling and drug screening | — |
| 12 | BioNTech IMFS Provider of CDMO specialized in cell and gene therapy products | $2M | 125 mo ago | 240 | Stephan Muller Co-Founder & MD | — | — | — | — |
| 13 | DERMAGO Provider of pharmaceutical development and consulting services. | $2M | 27 mo ago | 3 | Sven Schimansky-Wabra CEO | — | — | — | — |
| 14 | MJR PharmJet Pharmaceutical and biotechnology company that specializes in the development of innovative formulations and… | $2M | 96 mo ago | 11 | — | — | — | 17 patents Pharmaceutical micro/nanoparticle production and coating using microreactor technologies. | — |
| 15 | Synovo Provider of preclinical drug discovery services focused on inflammation and immunology | $1M | 60 mo ago | 33 | Michael Burnet Founder & Managing Director | WordPressMySQLPHP+13 | Top 50M | 77 patents Infection diagnostics and antiviral/immune‑modulating therapeutics for wound care and autoimmune diseases | — |
| 16 | Chimera Biotec Company offering bioanalytical services and immunoassay platforms for ultra sensitive large-molecule… | $1M | 117 mo ago | 11 | Mark Spengler CEO | TYPO3 CMSPHPLeaflet+9 | Top 10M | 20 patents Quantitative detection of biomolecules using conjugated assay reagents and optical devices. | — |
| 17 | Kinaxo Biotechnologies Chemical proteomics for cellular target profiling and drug discovery services | $1M | 198 mo ago | 5,460 | — | — | — | — | — |
| 18 | PAASP CRO focused on providing data handling, storage, and statistical analysis services | $1M | 76 mo ago | — | Christoph Emmerich Partner and Co-Founder | WordPressMySQLRedis+23 | Top 50M | — | — |
| 19 | Microcoat Provider of custom diagnostic and pharmaceutical services, including assay and product development | $1M | 65 mo ago | 213 213 → 133 (-38%) · sector median -12% | Wolfgang Mutter Founder & Owner | WordPressMySQLPHP+19 | Top 10M | 2 patents Automated detection devices for biological particles (e.g., pathogens, spores) | 3 job openings |
| 20 | Senetics Provider of regulatory support, marketing, QA services | $1M | 30 mo ago | 36 | — | WordPressMySQLPHP+26 | Top 10M | — | — |
| 21 | Axolabs Preclinical to commercial scale research services for developing oligonucleotide therapeutics | $947K | 67 mo ago | 118 118 → 215 (+82%) · sector median -12% | — | WordPressMySQLPHP+19 | Top 5M | 30 patents Sensitive detection technologies for oligonucleotide conjugates and nucleic acid diagnostics | — |
| 22 | Crelux X-ray crystallography, fragment based drug discovery and protein delivery. | $863K | 134 mo ago | 68 | Michael Schaeffer Founder & Owner | Animate.cssBootstrapApache HTTP Server+7 | Top 50M | — | — |
| 23 | PharmaLex CRO specializing in regulatory affairs and pharmacovigilance | $814K | 48 mo ago | 1,296 | — | WordPressApple iCloud MailMicrosoft 365+24 | Top 5M | — | — |
| 24 | GeneWerk Provider of gene therapy analytics, including vector safety and immune repertoire analysis | $716K | 101 mo ago | — | Christof Kalle Co-Founder | — | — | — | — |
| 25 | Signatope Toxicity testing, ADME studies, assay and antibody development services | $674K | 60 mo ago | 11 | — | — | — | — | — |
| 26 | PFÜTZNER Science & Health Institute CRO focused on preclinical phase II – IV preclinical studies | $647K | 68 mo ago | 13 | — | WordPressMySQLPHP+23 | Top 10M | — | — |
| 27 | ABX advanced biochemical compounds Provider of API & peptides development and PET precursors & FDG reagents kits distribution services | $646K | 59 mo ago | 350 | — | Neos CMSPHPNeos Flow+4 | Top 5M | 86 patents Silicon‑based PET radiotracers and bis‑aminothiol chelate complexes for diagnostic/therapeutic use | 2 job openings |
| 28 | Taros Provider of drug discovery services | $573K | 91 mo ago | 61 61 → 44 (-28%) · sector median -12% | — | Cart FunctionalityWordPressMySQL+20 | Top 50M | — | — |
| 29 | acromion Full service clinical CRO | $419K | 113 mo ago | 44 44 → 35 (-20%) · sector median -12% | Oana Braun Founder & MD | — | — | — | — |
| 30 | TransTissue Technologies Developer of tissue engineering products and regenerative medicine platform technologies | $418K | 65 mo ago | — | Michaela Endres CEO | — | — | 18 patents Cell‑free extracellular matrix scaffolds for tissue regeneration and wound healing | — |
| 31 | Profil Provider of clinical research services for diabetes and obesity studies | $226K | 53 mo ago | 201 201 → 214 (+6%) · sector median -12% | Med Leona Plum-Mörschel Chief Executive Officer | HubSpot CMS HubSentryWistia+12 | Top 10M | 2 patents Packaging and humidity monitoring for paper-based folded edge roller stock | 3 expansions |
| 32 | CeGaT Provider of drug research and development services to develop genetic causes of rare diseases | $109K | 125 mo ago | 113 | — | WordPressMySQLPHP+23 | Top 5M | — | — |
Top 12 Biopharma Outsourcing companies in Germany
#1
Series A · Karlsruhe, Baden-wurttemberg · founded 2017 · 29 employees$16.2Mraised▾
Developer of quantum simulation software for spectroscopy and related techniques. The software suite is designed for nuclear magnetic resonance analysis, turning spectra into chemical insight. It improves mixture analysis on compact low-field devices. The company delivers quantum mechanics-based analysis software that turns physics into industry-ready spectroscopy workflows.
- Jan 2025Grant (prize money)$2.6M
- Oct 2022Grant (prize money)$36.8K
- Jan 2022Series A$13.6M
- Nov 2020Grant (prize money)$294.3K
#2
Late Stage · Mesekenhagen, Mecklenburg Vorpommern · founded 1998 · 840 employees$547Mraised▾
Cheplapharm is a family-run pharmaceutical company headquartered in Germany that specializes in branded products worldwide. With a focus on long-standing and trusted pharma brands, the company has a high-growth platform approach, investing in and distributing products across various therapeutic areas. Cheplapharm has expanded its portfolio through strategic acquisitions and partnerships, solidifying its position as a global specialty pharmaceutical company.
- Oct 2022Convertible Debt$547M
- Nov 2018Conventional Debt$339.6M
- Jul 2018Conventional Debt$912M
- Oct 2016Conventional Debt$72M
#3
Seed · Berlin, Berlin · founded 2019 · 16 employees$7Mraised▾
Manufacturer of green active pharmaceutical ingredients and pharmaceutical intermediate chemicals. They apply green chemistry principles and digitalization to production processes. The company focuses on sustainable production, waste reduction, and resource reuse. They offer solutions for efficient synthesis design, upscaling, monitoring, and control of chemical production.
- Feb 2024Seed$7M
#4
Acquired · Starnberg, Bavaria · founded 2008 · 4200 employees$112.9Mraised▾
Aenova is a contract development and manufacturing organisation offering a range of services. The company offers its services for all standard dosage forms (solid, semi-solid and liquid) and product groups for medicinal and food supplements. Their service portfolio includes product development, including the development of formulations, preparation and packaging of clinical trial materials, coordination and organisation of clinical trials and dossier preparation for approval. Services also include production, research and development, analytical development, and supply chain management. The company operates in 27 locations in nine European countries, Asia and the USA.
- Mar 2020Conventional Debt$112.9M
- 2005PE—
#5
Seed · Heidelberg, Baden-wurttemberg · founded 2016$10.3Mraised▾
Provider of drug development & research services for peptides & gene therapy, and neurological diseases
- Nov 2022Seed$10.3M
- Jun 2021Seed—
#6
Seed · Strausberg, Brandenburg · founded 2019 · 3 employees$1.7Mraised▾
{}
- Feb 2024Seed$1.7M
#7
Series B · Germany · founded 2003 · 70 employees$17.5Mraised▾
Leukocare offers a proprietary formulation platform for the development of biologics. Their proprietary Stabilising and Protecting Solutions (SPS) platform offers technologies for increasing the stability and protection of therapeutic proteins in dry and liquid formulations. The platform mainly includes three major functionalities namely thermal stabilization, sterilization protection (for terminal sterilization and dry formulation of biologics) and device functionalization (for medical devices). The platform can be used mainly for the development of therapeutic antibodies, biosimilars, vaccines and medical devices. The company recently entered into a strategic alliance with Rentschler Biotechnologie, a Germany-based CDMO through which Leukocare would become its specialized technology partner and exclusive formulation developer.
- Jun 2021Series B$17.5M
- Jul 2015Series A—
#8
Funding Raised · Ansbach, Bavaria · founded 2009 · 36 employees$1.1Mraised▾
Provider of regulatory support, marketing, QA services
- Dec 2023Grant (prize money)$180.1K
- May 2020Grant (prize money)$442.2K
- Jan 2020Grant (prize money)$445K
#9
Acquired · Rheinbreitbach, Rhineland Palatinate · founded 2005 · 105 employees$17.6Mraised▾
Provider of nutritional, pharmaceutical, cosmetic and medical applications product development & research services
- Jul 2018Conventional Debt$17.6M
#10
Funding Raised · Frankfurt Am Main, Hesse · founded 2016 · 12 employees$3Mraised▾
Developer of therapies for cardiovascular and cardiometabolic diseases. The company focuses on therapeutic target and drug discovery for illnesses lacking effective treatments. It employs technology platforms to accelerate therapy development, specifically in cardiotoxicity, heart failure, and hypertrophic cardiomyopathy. Strategies involve cellular metabolic modulation and cardiac regeneration reactivation. The company utilizes Ai-driven data analysis and preclinical organoid models for therapeutic validation.
- Aug 2021Grant (prize money)$59K
- Sep 2018Grant (prize money)$2.8M
- Sep 2017Grant (prize money)$59K
- Jun 2017Grant (prize money)$56.1K
#11
Acquired · Laupheim, Baden Wurttemberg · founded 2005 · 30 employees$11.1Mraised▾
Cellca specializes in biopharmaceutical production in mammalian cells specifically for the industrial production environment. Its technology platform contains four different components: Expression System, Host Cell Line, Media System and Scale-up process. Cellca has partnered with GE Healthcare Bio-Sciences and Rentschler Biotechnology to develop its solutions. Sartorius Stedim Biotech acquired Cellca in 2015.
- May 2006PE$11.1M
#12
Public · Wiesbaden, Hesse · founded 2011 · 50 employees$4.7Mraised▾
Provider of contract research organization services for pharmaceutical and biotech industries. The company offers clinical study design, sample size justification, and scientific writing. Regulatory support, clinical study approval, and medical monitoring are also provided. Furthermore, the company offers clinical study management, project management, and site management. Biometrics, biostatistics, and data management are additional services.
- Aug 2020Series A$4.7M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Germany
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,297 Germany-affiliated papers.
- Heidelberg University85
- German Cancer Research Center49
- Ludwig-Maximilians-Universität München48
- Technical University of Munich43
- Karlsruhe Institute of Technology33
- Gene3→29
- Mutant3→19
- Transcription (linguistics)3→16
- Messenger RNA1→14
- Immune system1→12
- Gene3→20
- Agriculture2→12
- Extracellular1→11
- Immune system1→11
- Transcriptome1→9
- Antibiotic resistance2→9
- Gene1→7
- Agriculture4→9
- Antimicrobial1→4
- Microbiome1→4
Where biotechnology is researched across Germany
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in Germany
Germany biotechnology patent filing is cooling — 53,233 filings from 8,000 assignees (2016–2025), led by Immatics Biotechnologies, BASF Plant Science, BASF SE; annual filings 4819→4267.
- Immatics Biotechnologies4875
- BASF Plant Science4000
- BASF SE3548
- Boehringer Ingelheim INT3441
- Merck Patent3137
- MAX Planck Gesellschaft1805
- Evonik Degussa1684
- Amgen RES Munich1665
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.